163 related articles for article (PubMed ID: 27573075)
1. A-Disintegrin and Metalloproteinase (ADAM) 17 Enzymatically Degrades Interferon-gamma.
Kanzaki H; Shinohara F; Suzuki M; Wada S; Miyamoto Y; Yamaguchi Y; Katsumata Y; Makihira S; Kawai T; Taubman MA; Nakamura Y
Sci Rep; 2016 Aug; 6():32259. PubMed ID: 27573075
[TBL] [Abstract][Full Text] [Related]
2. Effects of ADAM10 and ADAM17 Inhibitors on Natural Killer Cell Expansion and Antibody-dependent Cellular Cytotoxicity Against Breast Cancer Cells
Pham DH; Kim JS; Kim SK; Shin DJ; Uong NT; Hyun H; Yoon MS; Kang SJ; Ryu YJ; Cho JS; Yoon JH; Lee JS; Cho D; Lee SH; Park MH
Anticancer Res; 2017 Oct; 37(10):5507-5513. PubMed ID: 28982863
[TBL] [Abstract][Full Text] [Related]
3. Interferon-gamma down-regulates expression of tumor necrosis factor-alpha converting enzyme/a disintegrin and metalloproteinase 17 in activated hepatic stellate cells of rats.
Fujita T; Maesawa C; Oikawa K; Nitta H; Wakabayashi G; Masuda T
Int J Mol Med; 2006 Apr; 17(4):605-16. PubMed ID: 16525716
[TBL] [Abstract][Full Text] [Related]
4. Epithelial Cell-Derived a Disintegrin and Metalloproteinase-17 Confers Resistance to Colonic Inflammation Through EGFR Activation.
Shimoda M; Horiuchi K; Sasaki A; Tsukamoto T; Okabayashi K; Hasegawa H; Kitagawa Y; Okada Y
EBioMedicine; 2016 Mar; 5():114-24. PubMed ID: 27077118
[TBL] [Abstract][Full Text] [Related]
5. Blockade of tumor necrosis factor-α converting enzyme (TACE) enhances IL-1β and IFN-γ via caspase-1 activation: a probable cause for loss of efficacy of TACE inhibitors in humans?
Sharma M; Mohapatra J; Acharya A; Deshpande SS; Chatterjee A; Jain MR
Eur J Pharmacol; 2013 Feb; 701(1-3):106-13. PubMed ID: 23266381
[TBL] [Abstract][Full Text] [Related]
6. The iRhom2/ADAM17 Axis Attenuates Bacterial Uptake by Phagocytes in a Cell Autonomous Manner.
Seifert A; Wozniak J; Düsterhöft S; Kasparek P; Sedlacek R; Dreschers S; Orlikowsky TW; Yildiz D; Ludwig A
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825187
[TBL] [Abstract][Full Text] [Related]
7. The role of p21 in interferon gamma-mediated growth inhibition of human breast cancer cells.
Gooch JL; Herrera RE; Yee D
Cell Growth Differ; 2000 Jun; 11(6):335-42. PubMed ID: 10910100
[TBL] [Abstract][Full Text] [Related]
8. Anti-ADAM17 monoclonal antibody MEDI3622 increases IFNγ production by human NK cells in the presence of antibody-bound tumor cells.
Mishra HK; Pore N; Michelotti EF; Walcheck B
Cancer Immunol Immunother; 2018 Sep; 67(9):1407-1416. PubMed ID: 29978334
[TBL] [Abstract][Full Text] [Related]
9. A novel bispecific single-chain antibody for ADAM17 and CD3 induces T-cell-mediated lysis of prostate cancer cells.
Yamamoto K; Trad A; Baumgart A; Hüske L; Lorenzen I; Chalaris A; Grötzinger J; Dechow T; Scheller J; Rose-John S
Biochem J; 2012 Jul; 445(1):135-44. PubMed ID: 22509934
[TBL] [Abstract][Full Text] [Related]
10. Stimulated release and functional activity of surface expressed metalloproteinase ADAM17 in exosomes.
Groth E; Pruessmeyer J; Babendreyer A; Schumacher J; Pasqualon T; Dreymueller D; Higashiyama S; Lorenzen I; Grötzinger J; Cataldo D; Ludwig A
Biochim Biophys Acta; 2016 Nov; 1863(11):2795-2808. PubMed ID: 27599715
[TBL] [Abstract][Full Text] [Related]
11. [Interleukin-12 restores and promotes the T-cell immune function inhibited by 5-fluorouracil].
Chi PD; Li L; Fan YY; Wu CY
Ai Zheng; 2007 Aug; 26(8):801-8. PubMed ID: 17697537
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of ADAM family members in human breast cancer and breast cancer cell lines.
Lendeckel U; Kohl J; Arndt M; Carl-McGrath S; Donat H; Röcken C
J Cancer Res Clin Oncol; 2005 Jan; 131(1):41-8. PubMed ID: 15565459
[TBL] [Abstract][Full Text] [Related]
13. The role of metalloproteinase ADAM17 in regulating ICOS ligand-mediated humoral immune responses.
Marczynska J; Ozga A; Wlodarczyk A; Majchrzak-Gorecka M; Kulig P; Banas M; Michalczyk-Wetula D; Majewski P; Hutloff A; Schwarz J; Chalaris A; Scheller J; Rose-John S; Cichy J
J Immunol; 2014 Sep; 193(6):2753-63. PubMed ID: 25108021
[TBL] [Abstract][Full Text] [Related]
14. T cell growth-promoting activity of interferon-gamma. Mitogenic effect of the recombinant cytokine on cells from a human T-chronic lymphocytic leukemia.
Alfinito F; Lamberti A; Capobianchi MR; Nigro M; De Rosa G; Tassone P; Turco MC; Dianzani F; Venuta S
Leukemia; 1994 Aug; 8(8):1294-300. PubMed ID: 8057665
[TBL] [Abstract][Full Text] [Related]
15. Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: heterogeneous involvement of the "a disintegrin and metalloproteases" 10 and 17.
Chitadze G; Lettau M; Bhat J; Wesch D; Steinle A; Fürst D; Mytilineos J; Kalthoff H; Janssen O; Oberg HH; Kabelitz D
Int J Cancer; 2013 Oct; 133(7):1557-66. PubMed ID: 23526433
[TBL] [Abstract][Full Text] [Related]
16. Interferon-gamma is produced by activated immature mouse thymocytes and inhibits the interleukin 4-induced proliferation of immature thymocytes.
Ransom J; Fischer M; Mosmann T; Yokota T; DeLuca D; Schumacher J; Zlotnik A
J Immunol; 1987 Dec; 139(12):4102-8. PubMed ID: 3121729
[TBL] [Abstract][Full Text] [Related]
17. Expression of IFN regulatory factor family proteins in lymphocytes. Induction of Stat-1 and IFN consensus sequence binding protein expression by T cell activation.
Nelson N; Kanno Y; Hong C; Contursi C; Fujita T; Fowlkes BJ; O'Connell E; Hu-Li J; Paul WE; Jankovic D; Sher AF; Coligan JE; Thornton A; Appella E; Yang Y; Ozato K
J Immunol; 1996 May; 156(10):3711-20. PubMed ID: 8621906
[TBL] [Abstract][Full Text] [Related]
18. (5R)-5-hydroxytriptolide inhibits IFN-gamma-related signaling.
Zhou R; Wang JX; Tang W; He PL; Yang YF; Li YC; Li XY; Zuo JP
Acta Pharmacol Sin; 2006 Dec; 27(12):1616-21. PubMed ID: 17112417
[TBL] [Abstract][Full Text] [Related]
19. Control of ADAM17 activity by regulation of its cellular localisation.
Lorenzen I; Lokau J; Korpys Y; Oldefest M; Flynn CM; Künzel U; Garbers C; Freeman M; Grötzinger J; Düsterhöft S
Sci Rep; 2016 Oct; 6():35067. PubMed ID: 27731361
[TBL] [Abstract][Full Text] [Related]
20. Activation of ADAM17 by IL-15 Limits Human NK Cell Proliferation.
Mishra HK; Dixon KJ; Pore N; Felices M; Miller JS; Walcheck B
Front Immunol; 2021; 12():711621. PubMed ID: 34367174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
